A54.0 Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess

Name of the Condition

• Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess

Summary

Gonococcal infection of the lower genitourinary tract without periurethral or accessory gland abscess is a sexually transmitted infection caused by Neisseria gonorrhoeae. It primarily affects the urethra, cervix, or other lower genitourinary structures, excluding abscess formation in periurethral or accessory glands. The condition is characterized by localized inflammation and may present with or without symptoms.

Causes

The infection is caused by Neisseria gonorrhoeae, a bacterium transmitted through sexual contact. The bacteria colonize the mucosal surfaces of the lower genitourinary tract, leading to infection. Transmission occurs via unprotected vaginal, oral, or anal sex with an infected partner.

Risk Factors

• Unprotected sexual activity with multiple partners
• History of prior gonococcal infections
• Young age (15–24 years)
• Presence of other sexually transmitted infections
• Lack of consistent condom use

Symptoms

• Dysuria (painful urination)
• Urethral or vaginal discharge
• Genital itching or irritation
• Mild lower abdominal pain
• Increased urinary frequency

Diagnosis

Diagnosis involves clinical evaluation and laboratory testing. Nucleic acid amplification tests (NAATs) on urine or genital swabs are commonly used to detect Neisseria gonorrhoeae. Gram staining of discharge may show gram-negative diplococci, and culture can confirm antibiotic susceptibility.

Treatment Options

• Antibiotic therapy: Ceftriaxone (intramuscular) plus azithromycin (oral) is the standard first-line treatment.
• Alternative regimens: Cefixime or spectinomycin may be used if ceftriaxone is contraindicated.
• Partner notification and treatment to prevent reinfection.

Prognosis and Follow-Up

With prompt and appropriate antibiotic treatment, the infection typically resolves within days. Follow-up testing 1–2 weeks post-treatment is recommended to confirm eradication. Untreated cases may lead to complications like pelvic inflammatory disease or infertility.

Complications

• Ascending infection to the upper genitourinary tract
• Pelvic inflammatory disease (in females)
• Epididymitis (in males)
• Increased risk of HIV transmission

Lifestyle & Prevention

• Consistent use of condoms during sexual activity
• Regular STI screening for sexually active individuals
• Limiting number of sexual partners
• Avoiding sexual contact until treatment is completed and symptoms resolve

When to Seek Professional Help

Seek medical attention if symptoms persist after treatment, worsen, or if new symptoms (e.g., fever, severe pain) develop. Prompt care is also advised for recurrent infections or exposure to an infected partner.

Tips for Medical Coders

Document the absence of periurethral or accessory gland abscess to support the code A54.0. Include details of infection site (e.g., urethra, cervix) and confirmatory test results. Ensure clinical notes align with the absence of abscess formation to avoid miscoding.